Regulation of human class i alcohol dehydrogenases by bile acids

Journal of Lipid Research

Volumn 54, Issue 9, 2013, Pages 2475-2484

  Langhi, Cédric ^a,b   Pedraz Cuesta, Elena ^a   Haro, Diego ^a   Marrero, Pedro F ^a   Rodríguez, Joan C ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ethanol; Farnesoid X receptor; Gene regulation; Liver metabolism

Indexed keywords

3 [2 [2 CHLORO 4 [3 (2,6 DICHLOROPHENYL) 5 ISOPROPYL 4 ISOXAZOLYLMETHOXY]PHENYL]VINYL]BENZOIC ACID; ALCOHOL DEHYDROGENASE; ALCOHOL DEHYDROGENASE 1A; ALCOHOL DEHYDROGENASE 1B; BILE ACID; CHENODEOXYCHOLIC ACID; CLASS I ALCOHOL DEHYDROGENASE; FARNESOID X RECEPTOR; MESSENGER RNA; UNCLASSIFIED DRUG;

ADH1A GENE; ADH1B GENE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

ETHANOL; FARNESOID X RECEPTOR; GENE REGULATION; LIVER METABOLISM;

ALCOHOL DEHYDROGENASE; ALCOHOLS; ANIMALS; BASE SEQUENCE; CHENODEOXYCHOLIC ACID; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEP G2 CELLS; HEPATOCYTES; HUMANS; ISOXAZOLES; LIGANDS; MALE; MICE; PROMOTER REGIONS, GENETIC; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REPETITIVE SEQUENCES, NUCLEIC ACID; RESPONSE ELEMENTS; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84883176700     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M039404     Document Type: Article

References (43)

1. Edenberg, H. J. 2000. Regulation of the mammalian alcohol dehydrogenase genes. Prog. Nucleic Acid Res. Mol. Biol. 64: 295-341.
2. Duester, G., J. Farres, M. R. Felder, R. S. Holmes, J. O. Hoog, X. Pares, B. V. Plapp, S. J. Yin, and H. Jornvall. 1999. Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. Biochem. Pharmacol. 58: 389-395.
3. Lee, S. L., G. Y. Chau, C. T. Yao, C. W. Wu, and S. J. Yin. 2006. Functional assessment of human alcohol dehydrogenase family in ethanol metabolism: significance of first-pass metabolism. Alcohol. Clin. Exp. Res. 30: 1132-1142.
4. Smith, M., D. A. Hopkinson, and H. Harris. 1971. Developmental changes and polymorphism in human alcohol dehydrogenase. Ann. Hum. Genet. 34: 251-271.
5. Stewart, M. J., M. S. McBride, L. A. Winter, and G. Duester. 1990. Promoters for the human alcohol dehydrogenase genes ADH1, ADH2, and ADH3: interaction of CCAAT/enhancer-binding protein with elements flanking the ADH2 TATA box. Gene. 90: 271-279.
6. Brown, C. J., L. Zhang, and H. J. Edenberg. 1996. Gene expression in a young multigene family: tissue-specific differences in the expression of the human alcohol dehydrogenase genes ADH1, ADH2, and ADH3. DNA Cell Biol. 15: 187-196.
7. van Ooij, C., R. C. Snyder, B. W. Paeper, and G. Duester. 1992. Temporal expression of the human alcohol dehydrogenase gene family during liver development correlates with differential promoter activation by hepatocyte nuclear factor 1, CCAAT/ enhancer-binding protein alpha, liver activator protein, and D-element-binding protein. Mol. Cell. Biol. 12: 3023-3031.
8. Su, J. S., T. F. Tsai, H. M. Chang, K. M. Chao, T. S. Su, and S. F. Tsai. 2006. Distant HNF1 site as a master control for the human class I alcohol dehydrogenase gene expression. J. Biol. Chem. 281: 19809-19821.
9. Lefebvre, P., B. Cariou, F. Lien, F. Kuipers, and B. Staels. 2009. Role of bile acids and bile acid receptors in metabolic regulation. Physiol. Rev. 89: 147-191.
10. Kalaany, N. Y., and D. J. Mangelsdorf. 2006. LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Annu. Rev. Physiol. 68: 159-191.
11. Moschetta, A., A. L. Bookout, and D. J. Mangelsdorf. 2004. Prevention of cholesterol gallstone disease by FXR agonists in a mouse model. Nat. Med. 10: 1352-1358.
12. Kovacs, P., R. Kress, J. Rocha, U. Kurtz, J. F. Miquel, F. Nervi, N. Mendez-Sanchez, M. Uribe, H. H. Bock, R. Schirin-Sokhan, et al. 2008. Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans. J. Hepatol. 48: 116-124.
13. Jonker, J. W., C. Liddle, and M. Downes. 2012. FXR and PXR: potential therapeutic targets in cholestasis. J. Steroid Biochem. Mol. Biol. 130: 147-158.
14. Adorini, L., M. Pruzanski, and D. Shapiro. 2012. Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis. Drug Discov. Today. 17: 988-997.
15. Gnerre, C., S. Blattler, M. R. Kaufmann, R. Looser, and U. A. Meyer. 2004. Regulation of CYP3A4 by the bile acid receptor FXR: evidence for functional binding sites in the CYP3A4 gene. Pharmacogenetics. 14: 635-645.
16. Lee, F. Y., T. Q. de Aguiar Vallim, H. K. Chong, Y. Zhang, Y. Liu, S. A. Jones, T. F. Osborne, and P. A. Edwards. 2010. Activation of the farnesoid X receptor provides protection against acetaminopheninduced hepatic toxicity. Mol. Endocrinol. 24: 1626-1636.
17. Mezey, E., and P. R. Holt. 1971. The inhibitory effect of ethanol on retinol oxidation by human liver and cattle retina. Exp. Mol. Pathol. 15: 148-156.
18. Okuda, A., and K. Okuda. 1983. Physiological function and kinetic mechanism of human liver alcohol dehydrogenase as 5 betacholestane- 3 alpha,7 alpha,12 alpha,26-tetrol dehydrogenase. J. Biol. Chem. 258: 2899-2905.
19. McEvily, A. J., B. Holmquist, D. S. Auld, and B. L. Vallee. 1988. 3 beta-Hydroxy-5 beta-steroid dehydrogenase activity of human liver alcohol dehydrogenase is specific to gamma-subunits. Biochemistry. 27: 4284-4288.
20. Marschall, H. U., U. C. Oppermann, S. Svensson, E. Nordling, B. Persson, J. O. Hoog, and H. Jornvall. 2000. Human liver class I alcohol dehydrogenase gammagamma isozyme: the sole cytosolic 3beta-hydroxysteroid dehydrogenase of iso bile acids. Hepatology. 31: 990-996.
21. Orellana-Gavaldà, J. M., L. Herrero, M. I. Malandrino, A. Paneda, M. Sol Rodriguez-Pena, H. Petry, G. Asins, S. Van Deventer, F. G. Hegardt, and D. Serra. 2011. Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation. Hepatology. 53: 821-832.
22. Modica, S., S. Murzilli, L. Salvatore, D. R. Schmidt, and A. Moschetta. 2008. Nuclear bile acid receptor FXR protects against intestinal tumorigenesis. Cancer Res. 68: 9589-9594.
23. Prieur, X., H. Coste, and J. C. Rodriguez. 2003. The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response element. J. Biol. Chem. 278: 25468-25480.
24. Urizar, N. L., D. H. Dowhan, and D. D. Moore. 2000. The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression. J. Biol. Chem. 275: 39313-39317.
25. Wang, L., Y. K. Lee, D. Bundman, Y. Han, S. Thevananther, C. S. Kim, S. S. Chua, P. Wei, R. A. Heyman, M. Karin, et al. 2002. Redundant pathways for negative feedback regulation of bile acid production. Dev. Cell. 2: 721-731.
26. Dwivedi, S. K., N. Singh, R. Kumari, J. S. Mishra, S. Tripathi, P. Banerjee, P. Shah, V. Kukshal, A. M. Tyagi, A. N. Gaikwad, et al. 2011. Bile acid receptor agonist GW4064 regulates PPARgamma coactivator-1alpha expression through estrogen receptor-related receptor alpha. Mol. Endocrinol. 25: 922-932.
27. Laffitte, B. A., H. R. Kast, C. M. Nguyen, A. M. Zavacki, D. D. Moore, and P. A. Edwards. 2000. Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor. J. Biol. Chem. 275: 10638-10647.
28. Thomas, A. M., S. N. Hart, B. Kong, J. Fang, X. B. Zhong, and G. L. Guo. 2010. Genome-wide tissue-specific farnesoid X receptor binding in mouse liver and intestine. Hepatology. 51: 1410-1419.
29. Peyer, A. K., D. Jung, M. Beer, C. Gnerre, A. Keogh, D. Stroka, M. Zavolan, and U. A. Meyer. 2007. Regulation of human liver delta-aminolevulinic acid synthase by bile acids. Hepatology. 46: 1960-1970.
30. Grober, J., I. Zaghini, H. Fujii, S. A. Jones, S. A. Kliewer, T. M. Willson, T. Ono, and P. Besnard. 1999. Identification of a bile acidresponsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer. J. Biol. Chem. 274: 29749-29754.
31. Sjövall, J., S. H. Andersson, and C. S. Lieber. 1985. Bile acids in deermice lacking liver alcohol dehydrogenase. Biochim. Biophys. Acta. 836: 8-13.
32. Holmberg-Betsholtz, I., E. Lund, I. Bjorkhem, and K. Wikvall. 1993. Sterol 27-hydroxylase in bile acid biosynthesis. Mechanism of oxidation of 5 beta-cholestane-3 alpha,7 alpha,12 alpha,27-tetrol into 3 alpha,7 alpha,12 alpha-trihydroxy-5 beta-cholestanoic acid. J. Biol. Chem. 268: 11079-11085.
33. Pikuleva, I. A., A. Babiker, M. R. Waterman, and I. Bjorkhem. 1998. Activities of recombinant human cytochrome P450c27 (CYP27) which produce intermediates of alternative bile acid biosynthetic pathways. J. Biol. Chem. 273: 18153-18160.
34. Nishimaki-Mogami, T., M. Une, T. Fujino, Y. Sato, N. Tamehiro, Y. Kawahara, K. Shudo, and K. Inoue. 2004. Identification of intermediates in the bile acid synthetic pathway as ligands for the farnesoid X receptor. J. Lipid Res. 45: 1538-1545.
35. Setchell, K. D., R. Dumaswala, C. Colombo, and M. Ronchi. 1988. Hepatic bile acid metabolism during early development revealed from the analysis of human fetal gallbladder bile. J. Biol. Chem. 263: 16637-16644.
36. Anisfeld, A. M., H. R. Kast-Woelbern, M. E. Meyer, S. A. Jones, Y. Zhang, K. J. Williams, T. Willson, and P. A. Edwards. 2003. Syndecan-1 expression is regulated in an isoform-specific manner by the farnesoid-X receptor. J. Biol. Chem. 278: 20420-20428.
37. Anisfeld, A. M., H. R. Kast-Woelbern, H. Lee, Y. Zhang, F. Y. Lee, and P. A. Edwards. 2005. Activation of the nuclear receptor FXR induces fibrinogen expression: a new role for bile acid signaling. J. Lipid Res. 46: 458-468.
38. Lee, F. Y., H. R. Kast-Woelbern, J. Chang, G. Luo, S. A. Jones, M. C. Fishbein, and P. A. Edwards. 2005. Alpha-crystallin is a target gene of the farnesoid X-activated receptor in human livers. J. Biol. Chem. 280: 31792-31800.
39. Pineda Torra, I., T. Claudel, C. Duval, V. Kosykh, J. C. Fruchart, and B. Staels. 2003. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor. Mol. Endocrinol. 17: 259-272.
40. Sirvent, A., A. J. Verhoeven, H. Jansen, V. Kosykh, R. J. Darteil, D. W. Hum, J. C. Fruchart, and B. Staels. 2004. Farnesoid X receptor represses hepatic lipase gene expression. J. Lipid Res. 45: 2110-2115.
41. Murakami, T., R. Walczak, S. Caron, C. Duhem, V. Vidal, R. Darteil, and B. Staels. 2007. The farnesoid X receptor induces fetuin-B gene expression in human hepatocytes. Biochem. J. 407: 461-469.
42. Langhi, C., C. Le May, S. Kourimate, S. Caron, B. Staels, M. Krempf, P. Costet, and B. Cariou. 2008. Activation of the farnesoid X receptor represses PCSK9 expression in human hepatocytes. FEBS Lett. 582: 949-955.
43. Oota, H., C. W. Dunn, W. C. Speed, A. J. Pakstis, M. A. Palmatier, J. R. Kidd, and K. K. Kidd. 2007. Conservative evolution in duplicated genes of the primate class I ADH cluster. Gene. 392: 64-76.